RecruitingNot Applicable

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

United States100 participantsStarted 2024-05-01

Plain-language summary

The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are admitted to Advanced Care at Home (ACH) Program and supposed to remain in ACH for at least 72 hours. * Patients with previous diagnosis of DM type 1 or type 2. * Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump. * Capable of giving signed informed consent Exclusion Criteria: * Actively treated for diabetes ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). * Participants taking acetaminophen more than 4g per day or more than 1gm every 6 hours. * Participants with altered mental status. * Participants diagnosed with dementia. * Patients with suicidal ideations or experiencing suicidal behavior. * Patients with liver cirrhosis. * Patients with End Stage Renal Disease on dialysis bot hemodialysis or peritoneal dialysis. * Participants with allergy to medical grade adhesive or medical tape. * Participants taking hydroxyurea. * Participants who are pregnant, wanting to become pregnant, or nursing during study period. * Patients with a planned MRI within the following 10 days after admission to ACH. * Participants currently using continuous glucose monitor (CGM) to dose insulin or check glucose level. * Participants with diabetes mellitus (DM) treated with diet alone. * Participants with DM treated with oral hypoglycemic medications. * Participants with DM treated with one SQ insulin injection daily. * Participants enrolled in other studies addressing CGM use. * Participants physically …

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Time in Range

Timeframe: 10 days

Mean daily glucose

Timeframe: 10 days

Trial details

NCT IDNCT05880810

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

View on ClinicalTrials.gov More Diabetes Mellitus trials